Canal of Nuck

From WikiMD's WELLNESSPEDIA

Anatomical illustration of the Canal of Nuck

The Canal of Nuck is an anatomical structure in the female human body, named after the Dutch anatomist, Anton Nuck. It is a tubular extension of the parietal peritoneum that follows the round ligament of the uterus into the labia majora.

Anatomy[edit]

The Canal of Nuck is a vestigial remnant of the processus vaginalis in females. In males, the processus vaginalis is obliterated after the descent of the testes, but in females, it may persist as the Canal of Nuck. The canal extends anterior to the round ligament of the uterus, through the inguinal canal, and terminates in the labia majora.

Clinical Significance[edit]

The Canal of Nuck can be a site for the development of hydroceles and hernias. A Nuck hydrocele is a collection of fluid within the canal, while a Nuck hernia involves the protrusion of abdominal contents through the canal. Both conditions can present with a painless swelling in the groin or labia majora and are typically diagnosed via ultrasound.

Diagnosis and Treatment[edit]

Diagnosis of conditions related to the Canal of Nuck is typically made via physical examination and confirmed with imaging studies, such as ultrasound or MRI. Treatment often involves surgical intervention to remove the hydrocele or repair the hernia.

History[edit]

The Canal of Nuck was first described by Anton Nuck in the 17th century. Nuck was a Dutch anatomist and surgeon who made significant contributions to the understanding of human anatomy.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.